DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Carmoterol is an investigational drug.
There have been 5 clinical trials for Carmoterol. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2008.
The most common disease conditions in clinical trials are Lung Diseases, Obstructive, Lung Diseases, and Pulmonary Disease, Chronic Obstructive. The leading clinical trial sponsors are Chiesi Farmaceutici S.p.A., Chiesi Pharmaceuticals Inc., and [disabled in preview].
Recent Clinical Trials for Carmoterol
|Cross-over Study to Evaluate the Effect on Trough Forced Expiratory Volume in One Second (FEV1) After 4 Weeks Treatment With CHF 5188 pMDI qd in Adult Patients With Persistent Asthma||Chiesi Farmaceutici S.p.A.||Phase 2|
|Safety and Efficacy Study of Treatment With Single Doses of CHF 4226 pMDI in Patients With Chronic Obstructive Pulmonary Disease (COPD)||Chiesi Pharmaceuticals Inc.||Phase 2|
|Evaluation of Possible Effects on the QTc Interval of CHF 4226 pMDI in Healthy Volunteers||Chiesi Pharmaceuticals Inc.||Phase 1|